Journal
OPEN FORUM INFECTIOUS DISEASES
Volume 8, Issue 8, Pages -Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofab369
Keywords
BNT162b2; SARS-CoV-2; transmission; vaccination
Categories
Funding
- Vaccine Research Institute
- IDEX AAP EMERGENCE-Universite de Paris (EMER-VEYER project)
- Mecenat COVID APHP-CUP
Ask authors/readers for more resources
This report describes a case of confirmed transmission of the SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of the BNT162b2 vaccine, despite antispike seroconversion.
Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a confirmed transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of BNT162b2, despite antispike seroconversion.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
